AzTrials
AzTrials

Pain, PostoperativeNCT06456853

Comparison of AI-Generated Pain Scoring Visuals With Visual Analog Scale (VAS) for Pain Assessment

An observational study of Pain, Postoperative, run by Kanuni Sultan Suleyman Training and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This prospective study will be conducted in surgical wards, assessing postoperative patients. Initially, patients will be evaluated using the VAS method. Subsequently, they will be shown five AI-generated images depicting different pain levels and will select the image that best represents their pain. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Pain, Postoperative
What is being tested?
Pain assesment
How many people
400 participants
Where
1 siteTurkey (Türkiye)
Study dates
14 Jun 2024to 2 Feb 2025
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: VAS scoring and pain assessment using visuals will be conducted on at least 398 patients aged 18 and above who have undergone any surgery, at any time within the first 24 hours postoperatively.

Who may be able to join

  • 18 years old and above
  • Underwent surgery for any reason
  • Consented to participate in the study and signed the informed consent form

Who cannot join

  • Patients under 18 years old
  • Patients who did not sign the informed consent form
  • Patients with visual impairments
  • Patients whose level of consciousness is not sufficient to complete the survey
  • Patients with a history of psychiatric disorders

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital

    Istanbul, 34303

Other trials in Turkey (Türkiye)

About this study

This prospective study will be conducted in surgical wards, assessing postoperative patients. Initially, patients will be evaluated using the VAS method. Subsequently, they will be shown five AI-generated images depicting different pain levels and will select the image that best represents their pain. A follow-up survey will assess the effectiveness of each method.

Using ChatGPT-4/DALL-E, images corresponding to VAS scores of 1-2, 3-4, 5-6, 7-8, and 9-10 will be created. Patients will choose the image that best describes their pain, aiming to determine if AI-supported visuals offer a more accurate alternative to VAS for pain assessment.

Read the detailed description

Study Objective The primary objective of this study is to compare and evaluate the effectiveness of AI-generated pain visuals in assisting patients to express their pain levels with the Visual Analog Scale (VAS). By allowing patients to more accurately depict their pain through AI-supported visuals, the study aims to enhance pain management practices in clinical settings.

Study Significance Pain management is a critical component of healthcare, directly impacting patient well-being and treatment success. The VAS is a widely used tool for subjective pain assessment but can be challenging for some patients due to its abstract nature. AI-generated visuals offer a potentially more precise and understandable way for patients to communicate their pain, potentially leading to more accurate and personalized pain assessments and management.

This study aims to measure the contribution of AI-generated pain visuals to more accurate pain assessment and to explore the potential applications of this technology. Additionally, the study seeks to understand the advantages and limitations of this approach compared to traditional methods like VAS, thereby enhancing the role of AI in pain management practices.

Expected Benefits and Risks

Expected Benefits:

Improved Pain Expression: AI-generated visuals may help patients articulate their pain more clearly, leading to better pain management in clinical settings.

Personalized Treatment Approaches: Enhanced pain expression can provide healthcare providers with opportunities to create more personalized treatment plans, especially beneficial for chronic pain patients.

Enhanced Clinical Decision-Making: The use of AI visuals may facilitate more objective and reproducible pain assessments, improving overall pain management strategies.

Potential Risks:

Misinterpretation Risk: AI-generated visuals might misinterpret patient pain in certain cases, especially if the visuals are misleading or complex.

Dependence on Technology: Over-reliance on AI tools may overlook the importance of human judgment and the subjective nature of pain assessment.

Study Design This prospective study will be conducted in surgical wards, assessing postoperative patients. Initially, patients will be evaluated using the conventional VAS method, which involves marking their pain on a 0-10 scale. Subsequently, patients will be shown five AI-generated images depicting different pain levels and asked to select the image that best represents their pain. A follow-up survey will assess which method the patients found more effective for expressing their pain.

VAS Scoring:

Patients will mark their pain level on a line ranging from 0 (no pain) to 10 (worst pain).

AI-Generated Visuals:

Using ChatGPT-4/DALL-E, images corresponding to VAS scores of 1-2, 3-4, 5-6, 7-8, and 9-10 will be created. These images will specifically depict facial expressions reflecting the respective pain levels. Patients will choose the image that best describes their pain.

This study aims to identify whether AI-supported visuals provide a more accurate and user-friendly alternative to traditional VAS scoring for pain assessment.

VAS Score Descriptions VAS Score 1-2: A middle-aged man showing signs of mild discomfort.

VAS Score 3-4: A young female athlete on a soccer field expressing moderate pain.

VAS Score 5-6: A man in a kitchen environment displaying severe pain from a cut.

VAS Score 7-8: A young male feeling severe shoulder pain.

VAS Score 9-10: A young woman experiencing intense pain.

Being tested
Pain assesment
Keywords
Postoperative Pain, Artificial Intelligence, Pain assesment
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pain assesmentOther

    We will ask patients about their pain and will try to asses their pain scores. Then we will ask them to which methot is more suitable for assesment.

Study groups in NCT06456853
Study groupRoleWhat they receive
Visual Analog Scale ScoreThe Visual Analog Scale (VAS) pain score is a simple and effective method used to measure patients' pain levels. This method is typically represented by a line ranging from 0 to 10, where 0 indicates no pain and 10 indicates the most severe pain. Patients are asked to mark a point on the line that corresponds to their level of pain.
Receives: Other: Pain assesment
Images maded by Artificial IntelligencePain assesment maded by images which is created from ChatGPT/DALLE
Receives: Other: Pain assesment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain assesment

    The primary outcome for this research is to compare the effectiveness of AI-generated pain assessment visuals with the traditional Visual Analog Scale (VAS) in accurately evaluating and expressing patients' pain levels. This will be measured through patient-reported ease of use, clarity, and usefulness of both methods, as well as patient preference for either method in pain assessment.

    Measured: 10 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jun 2024
  2. Study start14 Jun 2024
  3. Primary completion1 Feb 2025
  4. Study completion2 Feb 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
400 participants (actual)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT06456853
Sponsor's protocol ID
AI Images
Status last verified
Feb 2025
First submitted
8 Jun 2024
Last updated
21 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: All patients IPD will delete and we will give randomised patient number to them

Questions about this trial

What is this clinical trial studying?

An observational study of Pain, Postoperative, run by Kanuni Sultan Suleyman Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain assesment (time frame: 10 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2025; AzTrials last refreshed its copy on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in